Notice of Revised NHLBI Submission Policies for PA-14-047 “Midcareer Investigator Award in Patient-Oriented Research (Parent K24)"

Notice Number: NOT-HL-15-261

Key Dates
Release Date:   June 2, 2015

Related Announcements

January 13, 2022 - Notice of Information: Temporary Extension of Eligibility for NHLBI K24 Applicants Due to COVID-19. See Notice NOT-HL-22-007


Issued by
National Heart, Lung, and Blood Institute (NHLBI)


This Notice supersedes NOT-HL-11-133, and announces changes in NHLBI-specific requirements, listed in the Table of IC-Specific Information, Requirements and Staff Contacts, for the submission of Renewal applications and Individual Eligibility for PA-14-047, "Midcareer Investigator Award in Patient-Oriented Research (K24)" for applications due on October 12, 2015 and thereafter.

Renewal Applications
In addition to new applications, NHLBI will now accept renewal K24 applications that request 3.0 calendar months' (25% of full-time professional effort). Applications requesting more than 3.0 calendar months' (25% of full-time professional effort) will not be reviewed. The NHLBI K24 award may be renewed one time.

Individual Eligibility
At the time of application, individuals who are associate professors or full professors within 10 years of their appointment as an Associate Professor are eligible to submit a new NHLBI K24 application. The NHLBI will consider requests to extend the eligibility period for reasons that can include medical concerns, disability, family care responsibilities, natural disasters, and active duty military service. In general, the NHLBI will extend eligibility for a period equivalent to the time away from faculty service. Extensions related to periods of part-time status normally will be prorated to reflect the actual time away from faculty service and normally will be considered only when the appointment is reduced by 50% or more for a sustained period of time.

The K24 applicant (new or renewal) is required to have an active, independent, peer-reviewed R01 or R01-like grant funding, which includes peer-reviewed research grants from other federal sources, private foundations, or industry at the time of application. Grants under a no-cost extension do not qualify. The PD/PI is expected to maintain such research grant support during the project period.

An individual who holds R01 or R01-like funding, with a major focus on the analysis of large-scale clinical or population data, is eligible to apply provided the patient-oriented research (POR) requirements are met and the PD/PI proposes a research plan that will include POR training opportunities for mentees.

Potential applicants are strongly encouraged to read the complete Funding Opportunity Announcement (PA-14-047) and to contact the NHLBI Scientific Program Contact to discuss their eligibility and/or interests in this program.

All other aspects of this FOA remain unchanged and participation by other NIH Institutes continues, unaffected by this Notice.


Sandra Colombini Hatch, MD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0222